Athletics: Claims of unfair drug test denied
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.(First Edition)
HEINER HENZE, the general secretary of the European Athletic Association, denied that there had been any irregularities when a B sample provided by Paul Edwards, the British shot putter, tested positive on Tuesday.
Edwards, whose A sample from the European Championships in Helsinki in August tested positive, claimed the proper procedures had not been carried out, because he did not have a representative at the examination.
Under International Amateur Athletic Federation rules, an athlete is entitled to be represented when his second sample is tested. Henze, however, said the EAA had asked the British federation if it, or the athlete wanted to be present at the testing but had been told that Edwards was not available.
'After about three weeks without any further reply we informed the federation again that the analysis of the B sample would take place in three days' time,' he said. 'We did not get a reply so we went ahead with the sample.'
It has also been revealed that Colin Mackenzie, Britain's third-ranked javelin thrower, tested positive for the stimulant, dextropropoxphene, at a minor meeting in Italy on 24 July.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments